Skip to content

Implementation & Dissemination of a Digital Health Intervention for Adolescent Sleep

The Firefly Mobile App: A Digital Health Solution for Healthy Sleep in Teens

Status
Withdrawn
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06840444
Acronym
Firefly
Enrollment
0
Registered
2025-02-21
Start date
2025-04-01
Completion date
2025-12-01
Last updated
2026-04-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adolescent, Digital Health, Insomnia

Brief summary

The goal of this study is to form a Teen Advisory Board (TAB), who will partner with our study team to co-design a beta-test a new prototype of the Firefly program, a mobile-native insomnia cognitive behavioral therapy intervention for teens. This new prototype will have addressed issues that adolescents who had used the first version of the program deemed to be barriers to engaging with the treatment.

Detailed description

The aims of this study are to: 1) form a Teen Advisory Board (TAB) of teens with self-reported insomnia symptoms, 2) co-design a functional app prototype for sleep with TAB, 3) conduct two rounds of beta-testing to inform the iterative refinement of the app prototype. Participants will include 40 youth and their parents; 10 youth will participate in the TAB and first round 1 of beta-testing, and a separate cohort of 30 youth will participate in a second round of beta-testing. Youth will be ages 13-18 years and will have self-reported insomnia symptoms.

Interventions

BEHAVIORALFirefly Mobile App: A Digital Health Solution for Healthy Sleep in Teens

A six week cognitive behavioral therapy for insomnia program delivered via a mobile app.

Sponsors

University of Kansas Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
13 Years to 18 Years
Healthy volunteers
No

Inclusion criteria

* 13-18 years old * Self-reported insomnia symptoms

Exclusion criteria

* Non-English speaking

Design outcomes

Primary

MeasureTime frame
Program Completion PercentageImmediately post-treatment

Secondary

MeasureTime frame
Treatment Acceptability RatingsImmediately post-treatment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Apr 15, 2026